Back to Main

KKR adds to Amedisys position

By: InvestorsObserver
Posted: 11/22/2013 1:45:00 PM
Referenced Stocks: AMED

KKR adds to Amedisys position

Bobby Raines 11/22/2013

KKR Asset Management, already a beneficial owner of Amedisys ( AMED ) has been steadily adding to a position originally extablished last month. Most recently, KKR bought 425,515 share between Nov. 19 and Nov. 21. At prices between $14.39 and $14.77, KKR paid a total of $6,159,523 for the shares.

IK-> The technicals for AMED ($15.54 down $0.07) are bullish with an upward trend. Recent support has been around $14.13 and recent resistance has been around $15.89. Standard & Poor's does not follow the stock. Look at the March 10/12 bull-put spread for a 30-cent credit. That's an 17.65% return and the stock has to fall 22.8% to cause a problem.  [InvestorsKeyhole, Various news and data services]